Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Diabetes Medication Choice

This study has been completed.
American Diabetes Association
Information provided by:
Mayo Clinic Identifier:
First received: October 12, 2006
Last updated: April 27, 2015
Last verified: April 2015
The purpose of this study is to examine how different ways of sharing information about diabetes medication treatment options with patients can affect their choices and health.

Condition Intervention
Type 2 Diabetes
Behavioral: Diabetes Medication Choice decision aid
Behavioral: Usual Care

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double Blind (Participant, Investigator)
Primary Purpose: Treatment
Official Title: Wiser Choices for Patients With Type II Diabetes: Diabetes Medication Choice

Further study details as provided by Mayo Clinic:

Primary Outcome Measures:
  • Understanding [ Time Frame: Directly proceeding the clinical encounter ]
  • Decisional Conflict [ Time Frame: Directly proceeding the clinical visit ]
  • Treatment Action, adherence [ Time Frame: Directly proceeding the clinical encounter, 6 months after the clinical encounter ]

Secondary Outcome Measures:
  • Trust [ Time Frame: Directly proceeding the clinical visit ]
  • Acceptability [ Time Frame: Directly proceeding the clinical encounter ]

Enrollment: 85
Study Start Date: July 2006
Study Completion Date: October 2008
Primary Completion Date: October 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Diabetes Medication Choice decision aid
Patients in this arm will discuss diabetes medication for glucose control with the help of a decision aid that covers five commonly prescribed anti-hyperglycemic medications.
Behavioral: Diabetes Medication Choice decision aid
The decision aid covers five commonly prescribed anti-hyperglycemic medications and their attributes.
Usual Care
Patients and clinicians in this arm will discuss anti-hyperglycemic agents in their usual manner.
Behavioral: Usual Care
Patients and clinicians in this arm will discuss anti-hyperglycemic agents in their usual manner.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
  • Have a diagnosis of type 2 diabetes mellitus of any duration; c-peptide test not required
  • Use 1 or 2 oral hypoglycemic agents; not using insulin therapy
  • Are not pregnant
  • Have stable but inadequate glycemic control: both A1C at the time of eligibility and previous A1c within 6 months between 7-9.5%
  • Recognize their primary care provider as their main diabetes care provider
  • Do not have major barriers (i.e., severe hearing impairment, dementia, cannot communicate in English) to participate in shared decision-making (per provider?s assessment)
  • Have no plans to relocate out of town in the next 6 months
  • Enrolment is open to males and females of diverse racial backgrounds
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00388050

United States, Minnesota
Mayo Clinic
Rochester, Minnesota, United States, 55905
Sponsors and Collaborators
Mayo Clinic
American Diabetes Association
Principal Investigator: Victor M. Montori, M.D. Mayo Clinic
  More Information

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: Victor Montori, Mayo Clini Identifier: NCT00388050     History of Changes
Other Study ID Numbers: 06-003513
ADA #33
Study First Received: October 12, 2006
Last Updated: April 27, 2015

Keywords provided by Mayo Clinic:
Decision aid, diabetes, primary care

Additional relevant MeSH terms:
Diabetes Mellitus
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Hypoglycemic Agents
Physiological Effects of Drugs processed this record on May 25, 2017